These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats. Meng Y; Zhang H; Li Y; Li Q; Zuo L Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307 [TBL] [Abstract][Full Text] [Related]
3. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry. Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392 [TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635 [TBL] [Abstract][Full Text] [Related]
6. Bone histomorphometry in celiac disease. Arnala I; Kemppainen T; Kröger H; Janatuinen E; Alhava EM Ann Chir Gynaecol; 2001; 90(2):100-4. PubMed ID: 11459257 [TBL] [Abstract][Full Text] [Related]
7. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD). O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844 [TBL] [Abstract][Full Text] [Related]
8. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis? Joffe P; Heaf JG; Jensen C Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626 [TBL] [Abstract][Full Text] [Related]
9. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease . Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871 [TBL] [Abstract][Full Text] [Related]
10. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study. Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874 [TBL] [Abstract][Full Text] [Related]
11. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902 [TBL] [Abstract][Full Text] [Related]
12. Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation. Ballanti P; Coen G; Taggi F; Mazzaferro S; Perruzza I; Bonucci E Bone; 1995 May; 16(5):493-8. PubMed ID: 7654463 [TBL] [Abstract][Full Text] [Related]
13. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race. Soeiro EMD; Castro L; Menezes R; Elias RM; Dos Reis LM; Jorgetti V; Moysés RMA Pediatr Nephrol; 2020 Jul; 35(7):1297-1305. PubMed ID: 32157445 [TBL] [Abstract][Full Text] [Related]
14. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers . Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350 [TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056 [TBL] [Abstract][Full Text] [Related]
16. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease. Salam S; Gallagher O; Gossiel F; Paggiosi M; Eastell R; Khwaja A Bone; 2021 Feb; 143():115699. PubMed ID: 33091638 [TBL] [Abstract][Full Text] [Related]
17. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics. Pazianas M; Miller PD Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081 [TBL] [Abstract][Full Text] [Related]
19. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy. Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634 [TBL] [Abstract][Full Text] [Related]
20. Relationship between biochemical parameters of mineral bone disease and static bone histomorphometry in chronic kidney disease patients on hemodialysis: An Indian cross-section study. Chaturvedy M; Maurya SK; Bajpai NK; Jangid MK; Elhence P; Elhence A; Goel AD; Sharma P; Sharma PP; Jhorawat R Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():67-76. PubMed ID: 38355239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]